Rockwell Medical Technologies (RMTI) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Rockwell Medical Reports First Quarter 2015 Results
May 7, 2015 4:01 PM EDTWIXOM, Mich., May 7, 2015 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, reported results for the first quarter of 2015.
Q1 2015 Financial Highlights
Sales were $13.9 million, a 7.1% increase over Q1 2014. Gross profit was $2.3 million, a 37.6% increase over Q1 2014. Gross profit margins increased to 16.7% compared to 13.0% in Q1 2014. R&D expense was $0.8 million, a $3.8 million or 83% decrease... More